Our consultancy provides strategic direction and tactical execution for development of novel pharmaceuticals and medical devices

Development

Medical product development is a complex, expensive, risky venture. How does one get from early findings to an approved product? How do you get to the key milestones as rapidly and efficiently as possible?

Gary Novack, Ph.D.

Gary D. Novack, Ph.D., President of PharmaLogic Development, Inc. has decades of experience in successful product development.  Together with his team of senior experts, PharmaLogic can help you execute that plan.

BIO

Expertise

In our 25+ years working in manifold therapeutic areas with pharmaceuticals, biologics and devices, the firm’s particular expertise is in local therapy (ophthalmology and dermatology).

Based upon decades of successful product development experience, PharmaLogic Development, Inc., can help you develop and execute a strategic plan for your product. Working in manifold therapeutic areas with pharmaceuticals, biologics and devices, our expertise is in local therapy (ophthalmology and dermatology).

Dr. Novack states “The more I work in the development of new pharmaceuticals, the more I see that early development is a complex interaction of pharmaceutics (formulation), safety assessment (local and systemic), and clinical planning. Not only do we help plan and execute what needs to be done, but what needs to be done when.”

Many of his experiences and unique perspectives in product development may be found in the over two dozen editorials he has written as a contributing editor to The Ocular Surface.

If you don’t know where you are going, any road will get you there.
– Lewis Carroll

New pharmacotherapies for eye disease

Dr. Novack provided an update on novel therapies in pharmacotherapies in Ophthalmology Times.  He reviews treatments in all phases of clinical development, and those recently approved.  This is from anterior (dry eye, glaucoma) to posterior (wet AMD,...

read more